Co-Diagnostics, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Co-Diagnostics, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Co-Diagnostics, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $8.33M, a 61.9% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $8.33M +$3.18M +61.9% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $5.14M -$2.08M -28.8% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $7.23M +$6.68M +1221% Dec 31, 2021 10-K 2022-03-24
Q4 2020 $547K -$4.61M -89.4% Dec 31, 2020 10-K 2022-03-24
Q4 2019 $5.16M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.